Towards a TDP-43-Based Biomarker for ALS and FTLD.

about

Towards a TDP-43-Based Biomarker for ALS and FTLD.

Item

http://www.wikidata.org/entity/Q49823859

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Towards a TDP-43-Based Biomarker for ALS and FTLD.

@en

Towards a TDP-43-Based Biomarker for ALS and FTLD.

@nl

type

Item

label

Towards a TDP-43-Based Biomarker for ALS and FTLD.

@en

Towards a TDP-43-Based Biomarker for ALS and FTLD.

@nl

prefLabel

Towards a TDP-43-Based Biomarker for ALS and FTLD.

@en

Towards a TDP-43-Based Biomarker for ALS and FTLD.

@nl

P1476

Towards a TDP-43-Based Biomarker for ALS and FTLD

@en

P2093

Elizabeth Gray

http://www.w3.org/2001/XMLSchema#string

Olaf Ansorge

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

A harmonized classification system for FTLD-TDP pathology

Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia

TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease

Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

P2888

s12035-018-0947-6

P304

7789-7801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-018-0947-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin R. Turner

K Talbot

Emily Feneberg

P5008

ScienceSource

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101107020

http://www.w3.org/2001/XMLSchema#string

P698

29460270

http://www.w3.org/2001/XMLSchema#string

P921

Frontotemporal lobar degeneration

amyotrophic lateral sclerosis

DNA-binding protein

P932

6132775

http://www.w3.org/2001/XMLSchema#string